<DOC>
	<DOCNO>NCT00767494</DOCNO>
	<brief_summary>The purpose study compare IOP lower efficacy Travoprost/Brinzolamide dose daily morning evening , vs TRAVATAN dose daily evening , vs. AZOPT dose BID patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Travoprost/Brinzolamide Fixed Combination Versus Travatan Versus AZOPT</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>18 YOA old Either gender race OAG OHT Currently stable ( least 4 week ) IOP lower medication IOP screen visit â‰¥ 18mmHg least one eye Mean IOP eye ( eligibility 1 &amp; 2 visit 24 36 mmHg 9AM 21 36 mmHg 11AM 4PM Able discontinue use IOP lower medication minimum wash period 5 28 day prior eligibility visit 1 Related disease condition investigate ( OAG OHT ) either eye Severe central visual field loss Angle shaffer grade &lt; 2 C/D ratio &gt; 0.8 ( horizontal vertical measurement ) Related ocular patient history current ocular condition either eye BSCVA worse 55 ETDRS letter read ( equivalent approximately 20/80 Snellen 0.25 decimal ) Ocular infection inflammation laser surgery within last 3 month Intraocular surgery trauma last 6 month Any abnormality prevent reliable applanation tonometry History chronic , recurrently current severe inflammatory disease History current clinically significant progressive retinal disease History current ocular pathology ( include severe dry eye ) would affect conduct study Related systemic ocular medication either eye Allergy/hypersensitivity study medication Unable discontinue glucocorticoid least 4 week prior study unable remain medication study period Use oral CAIs study Recent use ( &lt; 4 week prior study ) Aspirin ( &gt; 1 gram ) Less 30 day stable dose regimen medication use chronic basis may affect IOP Therapy another investigational agent within 30 day prior Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>OAG</keyword>
	<keyword>OH</keyword>
	<keyword>Open-angle glaucoma ocular hypertension</keyword>
</DOC>